IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.

IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.

Item
http://www.wikidata.org/entity/Q41815870
Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease.Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects.Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells.Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation.Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging.Incorporation of Synthetic mRNA in Injectable Chitosan-Alginate Hybrid Hydrogels for Local and Sustained Expression of Exogenous Proteins in Cells.Therapeutic neovascularization promoted by injectable hydrogels.cardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patchesNovel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury
P2860

IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.

Item
http://www.wikidata.org/entity/Q41815870
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.
@en
type
label
IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.
@en
prefLabel
IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932